• wafik.eldeiry@gmail.com
  • Providence, Rhode Island

Wafik S. El-Deiry, MD, PhD, FACP

Lab Website

Publications

Public Index For Dr. El-Deiry's

This page is the public index for Dr. El-Deiry’s scholarly record. It is designed for verification, citation, and fast navigation across the main themes of his work, from foundational discoveries in p53 biology to translational oncology and precision cancer medicine.

At A Glance

Over 500 Publications

Over 115,000 citations in Google Scholar indexing

H-index 134 reported in 2026

Complete Publication Record And Profiles

PubMed Bibliography

PubMed is the standard biomedical literature index maintained by the U.S. National Library of Medicine. It is the cleanest source for peer-reviewed journal articles, stable citation metadata, and date-sorted browsing. It is also the most conservative record because it generally excludes items that are not indexed by PubMed.
Visit

Google Scholar Profile

Google Scholar is the broadest index and is useful for understanding citation footprint and influence across disciplines. It often includes preprints, books, chapters, conference items, and other scholarly material that may not appear in PubMed, and it is the most comprehensive view of total citations and citation trends.
Visit

ORCID

ORCID is an author-identity registry used to disambiguate researchers with similar names and to maintain a persistent scholarly identifier across institutions. It is the best verification anchor for identity and authorship mapping, and it can link publications and affiliations in a standardized way.
Visit

Selected Landmark Contributions

These are representative, high-impact contributions that map the arc of discovery to translation. The complete record and the most current indexing remain in the profiles above.

p21 (WAF1) and p53 tumor suppression (Cell, 1993)

Defined a p53-inducible checkpoint gene linking DNA damage to cell-cycle control and tumor suppression.
Visit

TRAIL receptor DR5 as a p53-regulated death receptor

Established a mechanistic bridge between p53 signaling and extrinsic apoptosis through death-receptor biology.
Visit

TIC10 / ONC201 discovery and platform development

Identified and advanced a small-molecule therapeutic platform engaging the TRAIL pathway and integrated stress response biology.
Visit

Diffuse midline glioma and precision oncology translation

Work contributing to clinical translation and mechanistic understanding of imipridone therapeutics in H3K27M-mutant diffuse midline glioma.
Visit

Browse By Publication Group

Each group below includes a short scope description and a direct PubMed link filtered to the author record plus the relevant topic terms.

Cancer Biology And Therapeutics

Mechanistic cancer biology with therapeutic implications, spanning core signaling, tumor suppressor pathways, and actionable vulnerabilities.
Visit

p53 Signaling And The Stress Response

Work defining and extending p53 pathway logic, including checkpoint control, transcriptional targets, and stress-response mechanisms.
Visit

Cell-Cycle Regulation And Tumor Suppression

Foundational contributions to checkpoint biology, including p21 (WAF1) and related control systems that determine proliferation versus arrest.
Visit

Apoptosis, Cell Death Pathways, And TRAIL Biology

Research on intrinsic and extrinsic apoptosis regulation, including TRAIL pathway biology, death receptors, and signaling determinants of cell fate.
Visit

Death Receptors And DR5

Focused publications centered on DR5, death-receptor signaling, and the connection between p53 activation and extrinsic apoptosis.
Visit

Translational Oncology And Experimental Therapeutics

Mechanism-to-therapy work emphasizing target validation, resistance logic, combination strategy, and clinically relevant models.
Visit

Imipridones: TIC10, ONC201, ONC206, ONC212

Preclinical and translational publications on imipridone therapeutics, including pathway effects, resistance biology, and rational synergy.
Visit

Integrated Stress Response

Work addressing integrated stress response biology, stress-adaptation, and therapeutic leverage points in resistant tumors.
Visit

Precision Oncology And Diffuse Midline Glioma

Publications relevant to precision oncology translation and diffuse midline glioma biology, including H3K27M-associated contexts.
Visit

Colorectal Cancer And Gastrointestinal Oncology

Clinical and translational work in colorectal cancer, including resistance mechanisms, pathway vulnerabilities, and precision strategy.
Visit

Tumor Microenvironment, Metabolism, And Immune Vulnerability

Work on how tumor context shapes immune killing, cytokine signaling, acidity and metabolic constraints, and response to therapy.
Visit

Clinical Oncology And Patient-Centered Translation

Clinical-facing publications and translational strategy documents oriented toward patient impact and real-world treatment constraints.
Visit

Reviews And Scholarly Commentary

Perspective and synthesis pieces intended to clarify mechanisms, standards, and translational logic across oncology.
Reviews

How To Use This Page

For completeness and the most current indexing, use the PubMed, Google Scholar, and ORCID links above. These sources provide the authoritative bibliography, citation trail, and date-sorted records used by institutions, collaborators, and reviewers.
Scroll to Top